Tranexamic Acid

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69918-301
  • Package NDC 69918-301-30
  • Application number NDA022430
  • SPL ID 7bafece1-f0b8-4852-92ca-fe2bf261be04
  • SPL set ID 031bf7c2-3b07-469d-bc5a-31fc6238e25f
  • UNII 6T84R30KC1
  • RxCUI 883826

What the source publishes

Labeler
Nordic Pharma, Inc.
Active ingredients
Tranexamic Acid
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69918-301_7bafece1-f0b8-4852-92ca-fe2bf261be04
{
  "name": "Tranexamic Acid",
  "splId": "7bafece1-f0b8-4852-92ca-fe2bf261be04",
  "labels": [
    {
      "setId": "031bf7c2-3b07-469d-bc5a-31fc6238e25f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=031bf7c2-3b07-469d-bc5a-31fc6238e25f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=031bf7c2-3b07-469d-bc5a-31fc6238e25f"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Nordic Pharma, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (69918-301-30)",
      "package_ndc": "69918-301-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160301"
    }
  ],
  "productId": "69918-301_7bafece1-f0b8-4852-92ca-fe2bf261be04",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "69918-301",
  "deaSchedule": null,
  "genericName": "Tranexamic Acid",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TRANEXAMIC ACID",
      "strength": "650 mg/1"
    }
  ],
  "applicationNumber": "NDA022430",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160301",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175634",
      "N0000175632"
    ],
    "unii": [
      "6T84R30KC1"
    ],
    "rxcui": [
      "883826"
    ],
    "spl_set_id": [
      "031bf7c2-3b07-469d-bc5a-31fc6238e25f"
    ],
    "pharm_class_pe": [
      "Decreased Fibrinolysis [PE]"
    ],
    "pharm_class_epc": [
      "Antifibrinolytic Agent [EPC]"
    ],
    "manufacturer_name": [
      "Nordic Pharma, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69918-301_7bafece1-f0b8-4852-92ca-fe2bf261be04"